TapewireFind a company

person · Reporting owner

ULLIAN ELAINE

Disclosed activity across 3 companies

Tapewire entity
15941
SEC CIK
0001190290

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
HOLOGIC INCHOLX · Entity 12463DirectorNovember 13, 2017November 15, 2017
THERMO FISHER SCIENTIFIC INC.TMO · Entity 2836DirectorMay 22, 2019May 23, 2019
VERTEX PHARMACEUTICALS INC / MAVRTX · Entity 2875DirectorJune 01, 2019June 04, 2019

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

HOLOGIC INC

Report date November 13, 2017 · Filed November 15, 2017

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect27,302 Last balance in matching sequence After 2017-11-14 transaction · row 3 Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
3 source rows

Row 1 · 2017-11-13 · Exercise / conversion · Acquired 9,282 · Balance 33,092

F1: Transaction pursuant to an existing rule 10b5-1 trading plan.

F2: Includes 3,260 shares subject to deferral pursuant to Issuer's Deferred Equity Plan.

Row 2 · 2017-11-13 · Sale · Disposed 9,282 · Balance 23,810

F1: Transaction pursuant to an existing rule 10b5-1 trading plan.

F2: Includes 3,260 shares subject to deferral pursuant to Issuer's Deferred Equity Plan.

Row 3 · 2017-11-14 · Exercise / conversion · Acquired 3,492 · Balance 27,302

F1: Transaction pursuant to an existing rule 10b5-1 trading plan.

F2: Includes 3,260 shares subject to deferral pursuant to Issuer's Deferred Equity Plan.

Non-qualified Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $18.82 · Expires 2018-01-01Direct3,492 Reported balance After 2017-11-13 transaction · row 4 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 4 · 2017-11-13 · Exercise / conversion · Disposed 9,282 · Balance 3,492

F1: Transaction pursuant to an existing rule 10b5-1 trading plan.

F3: This option became fully vested on January 1, 2008

Non-qualified Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $18.82 · Expires 2018-01-01Direct0 Reported balance After 2017-11-14 transaction · row 5 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 5 · 2017-11-14 · Exercise / conversion · Disposed 3,492 · Balance 0

F1: Transaction pursuant to an existing rule 10b5-1 trading plan.

F3: This option became fully vested on January 1, 2008

Filing footnotes · ownership attribution and instrument terms

F1: Transaction pursuant to an existing rule 10b5-1 trading plan.

F2: Includes 3,260 shares subject to deferral pursuant to Issuer's Deferred Equity Plan.

F3: This option became fully vested on January 1, 2008

THERMO FISHER SCIENTIFIC INC.

Report date May 22, 2019 · Filed May 23, 2019

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect4,706 Reported balance After 2019-05-22 transaction · row 1
1 source row

Row 1 · 2019-05-22 · Grant · Acquired 718 · Balance 4,706

Common StockSEC Table I · non-derivativeIndirectBy GRAT3,638 Reported balance Holding disclosure · report date 2019-05-22 · row 2 Holding and transaction disclosures are not merged.
1 source row

Row 2 · Balance 3,638

F1: These shares were previously reported as directly beneficially owned but were contributed to a grantor retained annuity trust on May 6, 2019.

Filing footnotes · ownership attribution and instrument terms

F1: These shares were previously reported as directly beneficially owned but were contributed to a grantor retained annuity trust on May 6, 2019.

VERTEX PHARMACEUTICALS INC / MA

Report date June 01, 2019 · Filed June 04, 2019

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $168.04 · Expires 2029-05-31Direct6,659 Reported balance After 2019-06-01 transaction · row 1 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 1 · 2019-06-01 · Grant · Acquired 6,659 · Balance 6,659

F1: Fully vested.

Filing footnotes · ownership attribution and instrument terms

F1: Fully vested.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
February 07, 2007 Filed Feb 8, 2007 18:46 UTC VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 Exercise / conversionStock Option · Derivative 2,500 $0.00 Strike: $11.62 $0.00
Disclosure

SEC source: 0000875320-07-000023 · edgar.xml · derivative · entry 11

ULLIAN ELAINE · CIK 0001190290 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,500 shares

Expires 2007-12-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: Fully vested.

Read SEC document
February 07, 2007 Filed Feb 8, 2007 18:46 UTC VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 Exercise / conversionStock Option · Derivative 10,000 $0.00 Strike: $13.32 $0.00
Disclosure

SEC source: 0000875320-07-000023 · edgar.xml · derivative · entry 10

ULLIAN ELAINE · CIK 0001190290 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 10,000 shares

Expires 2015-05-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: Fully vested.

Read SEC document
February 07, 2007 Filed Feb 8, 2007 18:46 UTC VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 Exercise / conversionStock Option · Derivative 7,500 $0.00 Strike: $14.46 $0.00
Disclosure

SEC source: 0000875320-07-000023 · edgar.xml · derivative · entry 9

ULLIAN ELAINE · CIK 0001190290 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 7,500 shares

Expires 2013-05-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: Fully vested.

Read SEC document
February 07, 2007 Filed Feb 8, 2007 18:46 UTC VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 Exercise / conversionStock Option · Derivative 7,500 $0.00 Strike: $19.84 $0.00
Disclosure

SEC source: 0000875320-07-000023 · edgar.xml · derivative · entry 8

ULLIAN ELAINE · CIK 0001190290 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 7,500 shares

Expires 2012-05-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: Fully vested.

Read SEC document
February 07, 2007 Filed Feb 8, 2007 18:46 UTC VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 Exercise / conversionStock Option · Derivative 10,000 $0.00 Strike: $14.20 $0.00
Disclosure

SEC source: 0000875320-07-000023 · edgar.xml · derivative · entry 7

ULLIAN ELAINE · CIK 0001190290 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 10,000 shares

Expires 2008-05-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: Fully vested.

Read SEC document
February 07, 2007 Filed Feb 8, 2007 18:46 UTC VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 SaleCommon Stock 37,500 $32.89 $1,233,375.00
Disclosure

SEC source: 0000875320-07-000023 · edgar.xml · nonDerivative · entry 6

ULLIAN ELAINE · CIK 0001190290 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Read SEC document
February 07, 2007 Filed Feb 8, 2007 18:46 UTC VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 Exercise / conversionCommon Stock 2,500 $11.62 $29,050.00
Disclosure

SEC source: 0000875320-07-000023 · edgar.xml · nonDerivative · entry 5

ULLIAN ELAINE · CIK 0001190290 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,500

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 07, 2007 Filed Feb 8, 2007 18:46 UTC VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 Exercise / conversionCommon Stock 10,000 $13.32 $133,200.00
Disclosure

SEC source: 0000875320-07-000023 · edgar.xml · nonDerivative · entry 4

ULLIAN ELAINE · CIK 0001190290 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 07, 2007 Filed Feb 8, 2007 18:46 UTC VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 Exercise / conversionCommon Stock 7,500 $14.46 $108,450.00
Disclosure

SEC source: 0000875320-07-000023 · edgar.xml · nonDerivative · entry 3

ULLIAN ELAINE · CIK 0001190290 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 07, 2007 Filed Feb 8, 2007 18:46 UTC VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 Exercise / conversionCommon Stock 7,500 $19.84 $148,800.00
Disclosure

SEC source: 0000875320-07-000023 · edgar.xml · nonDerivative · entry 2

ULLIAN ELAINE · CIK 0001190290 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,500

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 07, 2007 Filed Feb 8, 2007 18:46 UTC VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 Exercise / conversionCommon Stock 10,000 $14.20 $142,000.00
Disclosure

SEC source: 0000875320-07-000023 · edgar.xml · nonDerivative · entry 1

ULLIAN ELAINE · CIK 0001190290 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 31, 2006 Filed Jan 4, 2007 22:25 UTC THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 GrantPhantom Stock Units · Derivative 644.13 Not disclosed Not disclosed
Disclosure

SEC source: 0000097745-07-000002 · ull455.xml · derivative · entry 1

ULLIAN ELAINE · CIK 0001190290 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 644.13

Underlying: Common Stock · 644.13 shares

Expires not disclosed

F1 · derivative.exercise_price: Convertible into Common Stock on a 1-for-1 basis.

F2 · price: Represents stock units credited to the Reporting Person's account as of December 31, 2006, at a price of $45.41 per unit pursuant to the Issuer's Deferred Compensation Plan for Directors (the 'Plan'). Director's fees and retainers are deferred quarterly under the Plan as Common Stock units based on the average of the opening and closing price of the stock as of the quarter end. The shares are distributable as stock upon cessation of director service (for any reason) or a change of control.

F2 · derivative.exercise_date: Represents stock units credited to the Reporting Person's account as of December 31, 2006, at a price of $45.41 per unit pursuant to the Issuer's Deferred Compensation Plan for Directors (the 'Plan'). Director's fees and retainers are deferred quarterly under the Plan as Common Stock units based on the average of the opening and closing price of the stock as of the quarter end. The shares are distributable as stock upon cessation of director service (for any reason) or a change of control.

F2 · derivative.expiration_date: Represents stock units credited to the Reporting Person's account as of December 31, 2006, at a price of $45.41 per unit pursuant to the Issuer's Deferred Compensation Plan for Directors (the 'Plan'). Director's fees and retainers are deferred quarterly under the Plan as Common Stock units based on the average of the opening and closing price of the stock as of the quarter end. The shares are distributable as stock upon cessation of director service (for any reason) or a change of control.

Read SEC document
November 16, 2006 Filed Nov 20, 2006 21:31 UTC THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 SaleCommon Stock 13,573 $43.72 $593,411.56
Disclosure

SEC source: 0000097745-06-000233 · ull411.xml · nonDerivative · entry 1

ULLIAN ELAINE · CIK 0001190290 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 500

Read SEC document
November 09, 2006 Filed Nov 15, 2006 01:06 UTC THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 GrantStock Option (Right to Buy) · Derivative 15,600 $0.00 Strike: $43.37 $0.00
Disclosure

SEC source: 0000097745-06-000206 · ull373.xml · derivative · entry 4

ULLIAN ELAINE · CIK 0001190290 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,600

Underlying: Common Stock · 15,600 shares

Expires 2013-11-09

F3 · derivative.exercise_date: The option vests in three equal annual installments beginning on November 9, 2007.

Read SEC document
November 09, 2006 Filed Nov 15, 2006 01:06 UTC THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 Exercise / conversionPhantom Stock Units · Derivative 13,573.93 Not disclosed Not disclosed
Disclosure

SEC source: 0000097745-06-000206 · ull373.xml · derivative · entry 3

ULLIAN ELAINE · CIK 0001190290 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 13,573.93 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each phantom stock unit was the economic equivalent of one share of TMO common stock. On November 9, 2006, 13,573 of the reporting person's phantom stock units were settled for an equal number of shares of TMO common stock, and the remaining .93 were settled for cash.

F1 · price: Each phantom stock unit was the economic equivalent of one share of TMO common stock. On November 9, 2006, 13,573 of the reporting person's phantom stock units were settled for an equal number of shares of TMO common stock, and the remaining .93 were settled for cash.

F2 · derivative.exercise_date: November 9, 2006

F2 · derivative.expiration_date: November 9, 2006

Read SEC document
November 09, 2006 Filed Nov 15, 2006 01:06 UTC THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 Disposition to issuerCommon Stock 0.93 $43.37 $40.33
Disclosure

SEC source: 0000097745-06-000206 · ull373.xml · nonDerivative · entry 2

ULLIAN ELAINE · CIK 0001190290 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,073

Read SEC document
November 09, 2006 Filed Nov 15, 2006 01:06 UTC THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 Exercise / conversionCommon Stock 13,573.93 Not disclosed Not disclosed
Disclosure

SEC source: 0000097745-06-000206 · ull373.xml · nonDerivative · entry 1

ULLIAN ELAINE · CIK 0001190290 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,073.93

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each phantom stock unit was the economic equivalent of one share of TMO common stock. On November 9, 2006, 13,573 of the reporting person's phantom stock units were settled for an equal number of shares of TMO common stock, and the remaining .93 were settled for cash.

Read SEC document
September 30, 2006 Filed Oct 3, 2006 18:33 UTC THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 GrantPhantom Stock Units · Derivative 628.97 Not disclosed Not disclosed
Disclosure

SEC source: 0000097745-06-000147 · ull329.xml · derivative · entry 1

ULLIAN ELAINE · CIK 0001190290 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,573.93

Underlying: Common Stock · 628.97 shares

Expires not disclosed

F1 · derivative.exercise_price: Convertible into Common Stock on a 1-for-1 basis.

F2 · price: Represents stock units credited to the Reporting Person's account as of September 30, 2006, at a price of $39.35 per unit pursuant to the Issuer's Deferred Compensation Plan for Directors (the 'Plan'). Director's fees and retainers are deferred quarterly under the Plan as Common Stock units based on (a) the average closing price of the stock for the 5 days prior to the end of the quarter with respect to fees and retainers deferred on or prior to December 31, 2004, and (b) the average of the opening and closing price of the stock as of the quarter end with respect to fees and retainers deferred after December 31, 2004. The shares are distributable as stock upon cessation of director service (for any reason), a change of control or, with respect to stock units credited for fees and retainers deferred on or prior to December 31, 2004 only, retirement from principal occupation.

F2 · derivative.exercise_date: Represents stock units credited to the Reporting Person's account as of September 30, 2006, at a price of $39.35 per unit pursuant to the Issuer's Deferred Compensation Plan for Directors (the 'Plan'). Director's fees and retainers are deferred quarterly under the Plan as Common Stock units based on (a) the average closing price of the stock for the 5 days prior to the end of the quarter with respect to fees and retainers deferred on or prior to December 31, 2004, and (b) the average of the opening and closing price of the stock as of the quarter end with respect to fees and retainers deferred after December 31, 2004. The shares are distributable as stock upon cessation of director service (for any reason), a change of control or, with respect to stock units credited for fees and retainers deferred on or prior to December 31, 2004 only, retirement from principal occupation.

F2 · derivative.expiration_date: Represents stock units credited to the Reporting Person's account as of September 30, 2006, at a price of $39.35 per unit pursuant to the Issuer's Deferred Compensation Plan for Directors (the 'Plan'). Director's fees and retainers are deferred quarterly under the Plan as Common Stock units based on (a) the average closing price of the stock for the 5 days prior to the end of the quarter with respect to fees and retainers deferred on or prior to December 31, 2004, and (b) the average of the opening and closing price of the stock as of the quarter end with respect to fees and retainers deferred after December 31, 2004. The shares are distributable as stock upon cessation of director service (for any reason), a change of control or, with respect to stock units credited for fees and retainers deferred on or prior to December 31, 2004 only, retirement from principal occupation.

Read SEC document
July 01, 2006 Filed Jul 5, 2006 17:29 UTC THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 GrantPhantom Stock Units · Derivative 638.89 Not disclosed Not disclosed
Disclosure

SEC source: 0000097745-06-000132 · ull328.xml · derivative · entry 1

ULLIAN ELAINE · CIK 0001190290 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,944.96

Underlying: Common Stock · 638.89 shares

Expires not disclosed

F1 · derivative.exercise_price: Convertible into Common Stock on a 1-for-1 basis.

F2 · price: Represents stock units credited to the Reporting Person's account as of July 1, 2006, at a price of $36.00 per unit pursuant to the Issuer's Deferred Compensation Plan for Directors (the 'Plan'). Director's fees and retainers are deferred quarterly under the Plan as Common Stock units based on (a) the average closing price of the stock for the 5 days prior to the end of the quarter with respect to fees and retainers deferred on or prior to December 31, 2004, and (b) the average of the opening and closing price of the stock as of the quarter end with respect to fees and retainers deferred after December 31, 2004. The shares are distributable as stock upon cessation of director service (for any reason), a change of control or, with respect to stock units credited for fees and retainers deferred on or prior to December 31, 2004 only, retirement from principal occupation.

F2 · derivative.exercise_date: Represents stock units credited to the Reporting Person's account as of July 1, 2006, at a price of $36.00 per unit pursuant to the Issuer's Deferred Compensation Plan for Directors (the 'Plan'). Director's fees and retainers are deferred quarterly under the Plan as Common Stock units based on (a) the average closing price of the stock for the 5 days prior to the end of the quarter with respect to fees and retainers deferred on or prior to December 31, 2004, and (b) the average of the opening and closing price of the stock as of the quarter end with respect to fees and retainers deferred after December 31, 2004. The shares are distributable as stock upon cessation of director service (for any reason), a change of control or, with respect to stock units credited for fees and retainers deferred on or prior to December 31, 2004 only, retirement from principal occupation.

F2 · derivative.expiration_date: Represents stock units credited to the Reporting Person's account as of July 1, 2006, at a price of $36.00 per unit pursuant to the Issuer's Deferred Compensation Plan for Directors (the 'Plan'). Director's fees and retainers are deferred quarterly under the Plan as Common Stock units based on (a) the average closing price of the stock for the 5 days prior to the end of the quarter with respect to fees and retainers deferred on or prior to December 31, 2004, and (b) the average of the opening and closing price of the stock as of the quarter end with respect to fees and retainers deferred after December 31, 2004. The shares are distributable as stock upon cessation of director service (for any reason), a change of control or, with respect to stock units credited for fees and retainers deferred on or prior to December 31, 2004 only, retirement from principal occupation.

Read SEC document
June 01, 2006 Filed Jun 2, 2006 16:54 UTC VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 GrantStock Option · Derivative 20,000 $0.00 Strike: $34.32 $0.00
Disclosure

SEC source: 0000875320-06-000047 · edgar.xml · derivative · entry 1

ULLIAN ELAINE · CIK 0001190290 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 75,000

Underlying: Common Stock · 20,000 shares

Expires 2016-05-31

F1 · derivative.exercise_date: Right to buy under 2006 Stock and Option Plan. Fully vested.

Read SEC document
May 24, 2006 Filed May 25, 2006 22:03 UTC THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 GrantStock Option (Right to Buy) · Derivative 10,500 $0.00 Strike: $36.75 $0.00
Disclosure

SEC source: 0000097745-06-000124 · ull325.xml · derivative · entry 1

ULLIAN ELAINE · CIK 0001190290 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,500

Underlying: Common Stock · 10,500 shares

Expires 2013-05-24

F1 · derivative.exercise_date: The option vests in three equal annual installments beginning on May 24, 2007.

Read SEC document
April 01, 2006 Filed Apr 4, 2006 19:57 UTC THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 GrantPhantom Stock Units · Derivative 708.12 Not disclosed Not disclosed
Disclosure

SEC source: 0000097745-06-000087 · ull319.xml · derivative · entry 1

ULLIAN ELAINE · CIK 0001190290 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,306.07

Underlying: Common Stock · 708.12 shares

Expires not disclosed

F1 · derivative.exercise_price: Convertible into Common Stock on a 1-for-1 basis.

F2 · price: Represents stock units credited to the Reporting Person's account as of April 1, 2006, at a price of $37.07 per unit pursuant to the Issuer's Deferred Compensation Plan for Directors (the 'Plan'). Director's fees and retainers are deferred quarterly under the Plan as Common Stock units based on (a) the average closing price of the stock for the 5 days prior to the end of the quarter with respect to fees and retainers deferred on or prior to December 31, 2004, and (b) the average of the opening and closing price of the stock as of the quarter end with respect to fees and retainers deferred after December 31, 2004. The shares are distributable as stock upon cessation of director service (for any reason), a change of control or, with respect to stock units credited for fees and retainers deferred on or prior to December 31, 2004 only, retirement from principal occupation.

F2 · derivative.exercise_date: Represents stock units credited to the Reporting Person's account as of April 1, 2006, at a price of $37.07 per unit pursuant to the Issuer's Deferred Compensation Plan for Directors (the 'Plan'). Director's fees and retainers are deferred quarterly under the Plan as Common Stock units based on (a) the average closing price of the stock for the 5 days prior to the end of the quarter with respect to fees and retainers deferred on or prior to December 31, 2004, and (b) the average of the opening and closing price of the stock as of the quarter end with respect to fees and retainers deferred after December 31, 2004. The shares are distributable as stock upon cessation of director service (for any reason), a change of control or, with respect to stock units credited for fees and retainers deferred on or prior to December 31, 2004 only, retirement from principal occupation.

F2 · derivative.expiration_date: Represents stock units credited to the Reporting Person's account as of April 1, 2006, at a price of $37.07 per unit pursuant to the Issuer's Deferred Compensation Plan for Directors (the 'Plan'). Director's fees and retainers are deferred quarterly under the Plan as Common Stock units based on (a) the average closing price of the stock for the 5 days prior to the end of the quarter with respect to fees and retainers deferred on or prior to December 31, 2004, and (b) the average of the opening and closing price of the stock as of the quarter end with respect to fees and retainers deferred after December 31, 2004. The shares are distributable as stock upon cessation of director service (for any reason), a change of control or, with respect to stock units credited for fees and retainers deferred on or prior to December 31, 2004 only, retirement from principal occupation.

Read SEC document
December 31, 2005 Filed Jan 4, 2006 21:52 UTC THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 GrantPhantom Stock Units · Derivative 585.04 Not disclosed Not disclosed
Disclosure

SEC source: 0000097745-06-000002 · ull302.xml · derivative · entry 1

ULLIAN ELAINE · CIK 0001190290 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,597.95

Underlying: Common Stock · 585.04 shares

Expires not disclosed

F1 · derivative.exercise_price: Convertible into Common Stock on a 1-for-1 basis.

F2 · price: Represents stock units credited to the Reporting Person's account as of December 31, 2005, at a price of $30.34 per unit pursuant to the Issuer's Deferred Compensation Plan for Directors (the 'Plan'). Director's fees and retainers are deferred quarterly under the Plan as Common Stock units based on (a) the average closing price of the stock for the 5 days prior to the end of the quarter with respect to fees and retainers deferred on or prior to December 31, 2004, and (b) the average of the opening and closing price of the stock as of the quarter end with respect to fees and retainers deferred after December 31, 2004. The shares are distributable as stock upon cessation of director service (for any reason), a change of control or, with respect to stock units credited for fees and retainers deferred on or prior to December 31, 2004 only, retirement from principal occupation.

F2 · derivative.exercise_date: Represents stock units credited to the Reporting Person's account as of December 31, 2005, at a price of $30.34 per unit pursuant to the Issuer's Deferred Compensation Plan for Directors (the 'Plan'). Director's fees and retainers are deferred quarterly under the Plan as Common Stock units based on (a) the average closing price of the stock for the 5 days prior to the end of the quarter with respect to fees and retainers deferred on or prior to December 31, 2004, and (b) the average of the opening and closing price of the stock as of the quarter end with respect to fees and retainers deferred after December 31, 2004. The shares are distributable as stock upon cessation of director service (for any reason), a change of control or, with respect to stock units credited for fees and retainers deferred on or prior to December 31, 2004 only, retirement from principal occupation.

F2 · derivative.expiration_date: Represents stock units credited to the Reporting Person's account as of December 31, 2005, at a price of $30.34 per unit pursuant to the Issuer's Deferred Compensation Plan for Directors (the 'Plan'). Director's fees and retainers are deferred quarterly under the Plan as Common Stock units based on (a) the average closing price of the stock for the 5 days prior to the end of the quarter with respect to fees and retainers deferred on or prior to December 31, 2004, and (b) the average of the opening and closing price of the stock as of the quarter end with respect to fees and retainers deferred after December 31, 2004. The shares are distributable as stock upon cessation of director service (for any reason), a change of control or, with respect to stock units credited for fees and retainers deferred on or prior to December 31, 2004 only, retirement from principal occupation.

Read SEC document
December 02, 2005 Filed Dec 5, 2005 19:18 UTC Amendment VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 SaleCommon Stock 600 $25.03 $15,018.00
Disclosure

SEC source: 0000875320-05-000069 · edgar.xml · nonDerivative · entry 1

ULLIAN ELAINE · CIK 0001190290 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · date: This Form 4 amends the Form 4 filed on behalf of Ms. Ullian on November 28, 2005 to reflect a different transaction date and price.

Read SEC document
November 28, 2005 Filed Nov 29, 2005 18:42 UTC VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 SaleCommon Stock 600 $25.39 $15,234.00
Disclosure

SEC source: 0000875320-05-000067 · edgar.xml · nonDerivative · entry 1

ULLIAN ELAINE · CIK 0001190290 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Read SEC document
November 15, 2005 Filed Nov 18, 2005 19:18 UTC VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 GrantStock Option · Derivative 37,500 $26.27 Strike: $11.62 $985,125.00
Disclosure

SEC source: 0000875320-05-000065 · edgar.xml · derivative · entry 9

ULLIAN ELAINE · CIK 0001190290 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 55,000

Underlying: Common Stock · 37,500 shares

Expires 2007-12-11

F2 · derivative.exercise_date: Right to buy under 1996 Stock and Option Plan, vesting in equal quarterly installment over four years from 12/12/1997.

Read SEC document
November 15, 2005 Filed Nov 18, 2005 19:18 UTC VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 GrantStock Option · Derivative 7,500 $0.00 Strike: $9.09 $0.00
Disclosure

SEC source: 0000875320-05-000065 · edgar.xml · derivative · entry 8

ULLIAN ELAINE · CIK 0001190290 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 925,000

Underlying: Common Stock · 7,500 shares

Expires 2014-05-31

F1 · derivative.exercise_date: Right to buy under 1996 Stock and Option Plan. Fully vested on grant date.

Read SEC document
November 15, 2005 Filed Nov 18, 2005 19:18 UTC VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 GrantStock Option · Derivative 10,000 $0.00 Strike: $10.05 $0.00
Disclosure

SEC source: 0000875320-05-000065 · edgar.xml · derivative · entry 7

ULLIAN ELAINE · CIK 0001190290 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Common Stock · 10,000 shares

Expires 2009-05-31

F1 · derivative.exercise_date: Right to buy under 1996 Stock and Option Plan. Fully vested on grant date.

Read SEC document
November 15, 2005 Filed Nov 18, 2005 19:18 UTC VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 SaleCommon Stock 37,500 $26.27 $985,125.00
Disclosure

SEC source: 0000875320-05-000065 · edgar.xml · nonDerivative · entry 6

ULLIAN ELAINE · CIK 0001190290 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 600

Read SEC document
November 15, 2005 Filed Nov 18, 2005 19:18 UTC VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 Exercise / conversionCommon Stock 37,500 $11.62 $435,750.00
Disclosure

SEC source: 0000875320-05-000065 · edgar.xml · nonDerivative · entry 5

ULLIAN ELAINE · CIK 0001190290 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 15, 2005 Filed Nov 18, 2005 19:18 UTC VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 SaleCommon Stock 7,500 $26.30 $197,250.00
Disclosure

SEC source: 0000875320-05-000065 · edgar.xml · nonDerivative · entry 4

ULLIAN ELAINE · CIK 0001190290 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 600

Read SEC document
November 15, 2005 Filed Nov 18, 2005 19:18 UTC VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 Exercise / conversionCommon Stock 7,500 $9.09 $68,175.00
Disclosure

SEC source: 0000875320-05-000065 · edgar.xml · nonDerivative · entry 3

ULLIAN ELAINE · CIK 0001190290 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,100

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 15, 2005 Filed Nov 18, 2005 19:18 UTC VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 SaleCommon Stock 10,000 $26.27 $262,700.00
Disclosure

SEC source: 0000875320-05-000065 · edgar.xml · nonDerivative · entry 2

ULLIAN ELAINE · CIK 0001190290 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 600

Read SEC document
November 15, 2005 Filed Nov 18, 2005 19:18 UTC VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 Exercise / conversionCommon Stock 10,000 $10.05 $100,500.00
Disclosure

SEC source: 0000875320-05-000065 · edgar.xml · nonDerivative · entry 1

ULLIAN ELAINE · CIK 0001190290 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,600

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
October 01, 2005 Filed Oct 3, 2005 20:51 UTC THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 GrantPhantom Stock Units · Derivative 641.23 Not disclosed Not disclosed
Disclosure

SEC source: 0000097745-05-000139 · ull301.xml · derivative · entry 1

ULLIAN ELAINE · CIK 0001190290 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,012.91

Underlying: Common Stock · 641.23 shares

Expires not disclosed

F1 · derivative.exercise_price: Convertible into Common Stock on a 1-for-1 basis.

F2 · price: Represents stock units credited to the Reporting Person's account as of October 1, 2005, at a price of $30.80 per unit pursuant to the Issuer's Deferred Compensation Plan for Directors (the 'Plan'). Director's fees and retainers are deferred quarterly under the Plan as Common Stock units based on (a) the average closing price of the stock for the 5 days prior to the end of the quarter with respect to fees and retainers deferred on or prior to December 31, 2004, and (b) the average of the opening and closing price of the stock as of the quarter end with respect to fees and retainers deferred after December 31, 2004. The shares are distributable as stock upon cessation of director service (for any reason), a change of control or, with respect to stock units credited for fees and retainers deferred on or prior to December 31, 2004 only, retirement from principal occupation.

F2 · derivative.exercise_date: Represents stock units credited to the Reporting Person's account as of October 1, 2005, at a price of $30.80 per unit pursuant to the Issuer's Deferred Compensation Plan for Directors (the 'Plan'). Director's fees and retainers are deferred quarterly under the Plan as Common Stock units based on (a) the average closing price of the stock for the 5 days prior to the end of the quarter with respect to fees and retainers deferred on or prior to December 31, 2004, and (b) the average of the opening and closing price of the stock as of the quarter end with respect to fees and retainers deferred after December 31, 2004. The shares are distributable as stock upon cessation of director service (for any reason), a change of control or, with respect to stock units credited for fees and retainers deferred on or prior to December 31, 2004 only, retirement from principal occupation.

F2 · derivative.expiration_date: Represents stock units credited to the Reporting Person's account as of October 1, 2005, at a price of $30.80 per unit pursuant to the Issuer's Deferred Compensation Plan for Directors (the 'Plan'). Director's fees and retainers are deferred quarterly under the Plan as Common Stock units based on (a) the average closing price of the stock for the 5 days prior to the end of the quarter with respect to fees and retainers deferred on or prior to December 31, 2004, and (b) the average of the opening and closing price of the stock as of the quarter end with respect to fees and retainers deferred after December 31, 2004. The shares are distributable as stock upon cessation of director service (for any reason), a change of control or, with respect to stock units credited for fees and retainers deferred on or prior to December 31, 2004 only, retirement from principal occupation.

Read SEC document
July 02, 2005 Filed Jul 6, 2005 18:37 UTC THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 GrantPhantom Stock Units · Derivative 689.01 Not disclosed Not disclosed
Disclosure

SEC source: 0000097745-05-000107 · ull285.xml · derivative · entry 1

ULLIAN ELAINE · CIK 0001190290 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,371.68

Underlying: Common Stock · 689.01 shares

Expires not disclosed

F1 · derivative.exercise_price: Convertible into Common Stock on a 1-for-1 basis.

F2 · price: Represents stock units credited to the Reporting Person's account as of July 2, 2005, at a price of $26.85 per unit pursuant to the Issuer's Deferred Compensation Plan for Directors (the 'Plan'). Director's fees and retainers are deferred quarterly under the Plan as Common Stock units based on (a) the average closing price of the stock for the 5 days prior to the end of the quarter with respect to fees and retainers deferred on or prior to December 31, 2004, and (b) the average of the opening and closing price of the stock as of the quarter end with respect to fees and retainers deferred after December 31, 2004. The shares are distributable as stock upon cessation of director service (for any reason), a change of control or, with respect to stock units credited for fees and retainers deferred on or prior to December 31, 2004 only, retirement from principal occupation.

F2 · derivative.exercise_date: Represents stock units credited to the Reporting Person's account as of July 2, 2005, at a price of $26.85 per unit pursuant to the Issuer's Deferred Compensation Plan for Directors (the 'Plan'). Director's fees and retainers are deferred quarterly under the Plan as Common Stock units based on (a) the average closing price of the stock for the 5 days prior to the end of the quarter with respect to fees and retainers deferred on or prior to December 31, 2004, and (b) the average of the opening and closing price of the stock as of the quarter end with respect to fees and retainers deferred after December 31, 2004. The shares are distributable as stock upon cessation of director service (for any reason), a change of control or, with respect to stock units credited for fees and retainers deferred on or prior to December 31, 2004 only, retirement from principal occupation.

F2 · derivative.expiration_date: Represents stock units credited to the Reporting Person's account as of July 2, 2005, at a price of $26.85 per unit pursuant to the Issuer's Deferred Compensation Plan for Directors (the 'Plan'). Director's fees and retainers are deferred quarterly under the Plan as Common Stock units based on (a) the average closing price of the stock for the 5 days prior to the end of the quarter with respect to fees and retainers deferred on or prior to December 31, 2004, and (b) the average of the opening and closing price of the stock as of the quarter end with respect to fees and retainers deferred after December 31, 2004. The shares are distributable as stock upon cessation of director service (for any reason), a change of control or, with respect to stock units credited for fees and retainers deferred on or prior to December 31, 2004 only, retirement from principal occupation.

Read SEC document
June 01, 2005 Filed Jun 3, 2005 15:08 UTC VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 GrantStock Option · Derivative 10,000 $0.00 Strike: $13.32 $0.00
Disclosure

SEC source: 0000875320-05-000031 · edgar.xml · derivative · entry 1

ULLIAN ELAINE · CIK 0001190290 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 110,000

Underlying: Common Stock · 10,000 shares

Expires 2015-05-31

F1 · derivative.exercise_date: Right to buy under 1996 Stock and Option Plan. Fully vested.

Read SEC document
May 17, 2005 Filed May 19, 2005 21:10 UTC THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 GrantStock Option (Right to Buy) · Derivative 7,500 $0.00 Strike: $26.53 $0.00
Disclosure

SEC source: 0000097745-05-000086 · ull281.xml · derivative · entry 1

ULLIAN ELAINE · CIK 0001190290 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,500

Underlying: Common Stock · 7,500 shares

Expires 2012-05-17

F1 · derivative.exercise_date: The option vests in three equal annual installments beginning on May 17, 2006.

Read SEC document
April 02, 2005 Filed Apr 5, 2005 22:13 UTC THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 GrantPhantom Stock Units · Derivative 784.04 Not disclosed Not disclosed
Disclosure

SEC source: 0000097745-05-000052 · ull267.xml · derivative · entry 1

ULLIAN ELAINE · CIK 0001190290 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,682.67

Underlying: Common Stock · 784.04 shares

Expires not disclosed

F1 · derivative.exercise_price: Convertible into Common Stock on a 1-for-1 basis.

F2 · price: Represents stock units credited to the Reporting Person's account as of April 2, 2005, at a price of $25.19 per unit pursuant to the Issuer's Deferred Compensation Plan for Directors (the 'Plan'). Director's fees and retainers are deferred quarterly under the Plan as Common Stock units based on (a) the average closing price of the stock for the 5 days prior to the end of the quarter with respect to fees and retainers deferred on or prior to December 31, 2004, and (b) the average of the opening and closing price of the stock as of the quarter end with respect to fees and retainers deferred after December 31, 2004. The shares are distributable as stock upon cessation of director service (for any reason), a change of control or, with respect to stock units credited for fees and retainers deferred on or prior to December 31, 2004 only, retirement from principal occupation.

F2 · derivative.exercise_date: Represents stock units credited to the Reporting Person's account as of April 2, 2005, at a price of $25.19 per unit pursuant to the Issuer's Deferred Compensation Plan for Directors (the 'Plan'). Director's fees and retainers are deferred quarterly under the Plan as Common Stock units based on (a) the average closing price of the stock for the 5 days prior to the end of the quarter with respect to fees and retainers deferred on or prior to December 31, 2004, and (b) the average of the opening and closing price of the stock as of the quarter end with respect to fees and retainers deferred after December 31, 2004. The shares are distributable as stock upon cessation of director service (for any reason), a change of control or, with respect to stock units credited for fees and retainers deferred on or prior to December 31, 2004 only, retirement from principal occupation.

F2 · derivative.expiration_date: Represents stock units credited to the Reporting Person's account as of April 2, 2005, at a price of $25.19 per unit pursuant to the Issuer's Deferred Compensation Plan for Directors (the 'Plan'). Director's fees and retainers are deferred quarterly under the Plan as Common Stock units based on (a) the average closing price of the stock for the 5 days prior to the end of the quarter with respect to fees and retainers deferred on or prior to December 31, 2004, and (b) the average of the opening and closing price of the stock as of the quarter end with respect to fees and retainers deferred after December 31, 2004. The shares are distributable as stock upon cessation of director service (for any reason), a change of control or, with respect to stock units credited for fees and retainers deferred on or prior to December 31, 2004 only, retirement from principal occupation.

Read SEC document
December 31, 2004 Filed Jan 4, 2005 18:27 UTC THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 GrantPhantom Stock Units · Derivative 652.03 Not disclosed Strike: $0.00 Not disclosed
Disclosure

SEC source: 0000097745-05-000002 · ull250.xml · derivative · entry 1

ULLIAN ELAINE · CIK 0001190290 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,898.63

Underlying: Common Stock · 652.03 shares

Expires not disclosed

F1 · derivative.exercise_price: Convertible into Common Stock on a 1-for-1 basis.

F2 · price: Represents stock units credited to the Reporting Person's account as of December 31, 2004, at a price of $30.29 per unit pursuant to the Issuer's exempt Deferred Compensation Plan for Directors (the 'Plan'). Director's fees and retainers are deferred quarterly under the Plan as Common Stock based on the average closing price of the stock for the 5 days prior to the end of the quarter and are distributable as stock upon cessation of director service, death, retirement or a change of control.

F2 · derivative.exercise_date: Represents stock units credited to the Reporting Person's account as of December 31, 2004, at a price of $30.29 per unit pursuant to the Issuer's exempt Deferred Compensation Plan for Directors (the 'Plan'). Director's fees and retainers are deferred quarterly under the Plan as Common Stock based on the average closing price of the stock for the 5 days prior to the end of the quarter and are distributable as stock upon cessation of director service, death, retirement or a change of control.

F2 · derivative.expiration_date: Represents stock units credited to the Reporting Person's account as of December 31, 2004, at a price of $30.29 per unit pursuant to the Issuer's exempt Deferred Compensation Plan for Directors (the 'Plan'). Director's fees and retainers are deferred quarterly under the Plan as Common Stock based on the average closing price of the stock for the 5 days prior to the end of the quarter and are distributable as stock upon cessation of director service, death, retirement or a change of control.

Read SEC document
October 02, 2004 Filed Oct 4, 2004 20:28 UTC THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 GrantPhantom Stock Units · Derivative 709.29 Not disclosed Strike: $0.00 Not disclosed
Disclosure

SEC source: 0000097745-04-000160 · ull248.xml · derivative · entry 1

ULLIAN ELAINE · CIK 0001190290 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,246.6

Underlying: Common Stock · 709.29 shares

Expires not disclosed

F1 · derivative.exercise_price: Convertible into Common Stock on a 1-for-1 basis.

F2 · price: Represents stock units credited to the Reporting Person's account as of October 2, 2004, at a price of $27.14 per unit pursuant to the Issuer's exempt Deferred Compensation Plan for Directors (the 'Plan'). Director's fees and retainers are deferred quarterly under the Plan as Common Stock based on the average closing price of the stock for the 5 days prior to the end of the quarter and are distributable as stock upon cessation of director service, death, retirement or a change of control.

F2 · derivative.exercise_date: Represents stock units credited to the Reporting Person's account as of October 2, 2004, at a price of $27.14 per unit pursuant to the Issuer's exempt Deferred Compensation Plan for Directors (the 'Plan'). Director's fees and retainers are deferred quarterly under the Plan as Common Stock based on the average closing price of the stock for the 5 days prior to the end of the quarter and are distributable as stock upon cessation of director service, death, retirement or a change of control.

F2 · derivative.expiration_date: Represents stock units credited to the Reporting Person's account as of October 2, 2004, at a price of $27.14 per unit pursuant to the Issuer's exempt Deferred Compensation Plan for Directors (the 'Plan'). Director's fees and retainers are deferred quarterly under the Plan as Common Stock based on the average closing price of the stock for the 5 days prior to the end of the quarter and are distributable as stock upon cessation of director service, death, retirement or a change of control.

Read SEC document
July 03, 2004 Filed Jul 6, 2004 20:43 UTC THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 GrantPhantom Stock Units · Derivative 614.01 Not disclosed Strike: $0.00 Not disclosed
Disclosure

SEC source: 0000097745-04-000135 · ull245.xml · derivative · entry 1

ULLIAN ELAINE · CIK 0001190290 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,537.31

Underlying: Common Stock · 614.01 shares

Expires not disclosed

F1 · derivative.exercise_price: Convertible into Common Stock on a 1-for-1 basis.

F2 · price: Represents stock units credited to the Reporting Person's account as of July 3, 2004, at a price of $30.13 per unit pursuant to the Issuer's exempt Deferred Compensation Plan for Directors (the 'Plan'). Director's fees and retainers are deferred quarterly under the Plan as Common Stock based on the average closing price of the stock for the 5 days prior to the end of the quarter and are distributable as stock upon cessation of director service, death, retirement or a change of control.

F2 · derivative.exercise_date: Represents stock units credited to the Reporting Person's account as of July 3, 2004, at a price of $30.13 per unit pursuant to the Issuer's exempt Deferred Compensation Plan for Directors (the 'Plan'). Director's fees and retainers are deferred quarterly under the Plan as Common Stock based on the average closing price of the stock for the 5 days prior to the end of the quarter and are distributable as stock upon cessation of director service, death, retirement or a change of control.

F2 · derivative.expiration_date: Represents stock units credited to the Reporting Person's account as of July 3, 2004, at a price of $30.13 per unit pursuant to the Issuer's exempt Deferred Compensation Plan for Directors (the 'Plan'). Director's fees and retainers are deferred quarterly under the Plan as Common Stock based on the average closing price of the stock for the 5 days prior to the end of the quarter and are distributable as stock upon cessation of director service, death, retirement or a change of control.

Read SEC document
June 07, 2004 Filed Jun 8, 2004 22:26 UTC THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 PurchaseCommon Stock 500 $30.00 $15,000.00
Disclosure

SEC source: 0000097745-04-000088 · ull224.xml · nonDerivative · entry 1

ULLIAN ELAINE · CIK 0001190290 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 500

Read SEC document
June 01, 2004 Filed Jun 2, 2004 14:53 UTC VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 GrantStock Option · Derivative 7,500 $0.00 Strike: $9.09 $0.00
Disclosure

SEC source: 0000875320-04-000063 · edgar.xml · derivative · entry 1

ULLIAN ELAINE · CIK 0001190290 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Common Stock · 7,500 shares

Expires 2014-05-31

F1 · derivative.exercise_date: Right to buy under 1996 Stock and Option Plan. Fully vested.

Read SEC document
May 18, 2004 Filed May 20, 2004 21:00 UTC THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 GrantStock Option (Right to Buy) · Derivative 7,500 $0.00 Strike: $28.73 $0.00
Disclosure

SEC source: 0000097745-04-000080 · ull220.xml · derivative · entry 1

ULLIAN ELAINE · CIK 0001190290 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,500

Underlying: Common Stock · 7,500 shares

Expires 2011-05-18

F1 · derivative.exercise_date: The option vests in three equal annual installments beginning on May 18, 2005.

Read SEC document
April 03, 2004 Filed Apr 6, 2004 20:42 UTC THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 GrantPhantom Stock Units · Derivative 720.06 Not disclosed Strike: $0.00 Not disclosed
Disclosure

SEC source: 0000097745-04-000044 · ull210.xml · derivative · entry 1

ULLIAN ELAINE · CIK 0001190290 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,923.3

Underlying: Common Stock · 720.06 shares

Expires not disclosed

F1 · derivative.exercise_price: Convertible into Common Stock on a 1-for-1 basis.

F2 · price: Represents stock units credited to the Reporting Person's account as of April 3, 2004, at a price of $28.47 per unit pursuant to the Issuer's exempt Deferred Compensation Plan for Directors (the 'Plan'). Director's fees and retainers are deferred quarterly under the Plan as Common Stock based on the average closing price of the stock for the 5 days prior to the end of the quarter and are distributable as stock upon cessation of director service, death, retirement or a change of control.

F2 · derivative.exercise_date: Represents stock units credited to the Reporting Person's account as of April 3, 2004, at a price of $28.47 per unit pursuant to the Issuer's exempt Deferred Compensation Plan for Directors (the 'Plan'). Director's fees and retainers are deferred quarterly under the Plan as Common Stock based on the average closing price of the stock for the 5 days prior to the end of the quarter and are distributable as stock upon cessation of director service, death, retirement or a change of control.

F2 · derivative.expiration_date: Represents stock units credited to the Reporting Person's account as of April 3, 2004, at a price of $28.47 per unit pursuant to the Issuer's exempt Deferred Compensation Plan for Directors (the 'Plan'). Director's fees and retainers are deferred quarterly under the Plan as Common Stock based on the average closing price of the stock for the 5 days prior to the end of the quarter and are distributable as stock upon cessation of director service, death, retirement or a change of control.

Read SEC document
December 31, 2003 Filed Jan 5, 2004 22:34 UTC THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 GrantPhantom Stock Units · Derivative 695.27 Not disclosed Strike: $0.00 Not disclosed
Disclosure

SEC source: 0000097745-04-000006 · ull197.xml · derivative · entry 1

ULLIAN ELAINE · CIK 0001190290 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,203.24

Underlying: Common Stock · 695.27 shares

Expires not disclosed

F1 · derivative.exercise_price: Convertible into Common Stock on a 1-for-1 basis.

F2 · price: Represents stock units credited to the Reporting Person's account as of December 31, 2003, at a price of $25.17 per unit pursuant to the Issuer's exempt Deferred Compensation Plan for Directors (the 'Plan'). Director's fees and retainers are deferred quarterly under the Plan as Common Stock based on the average closing price of the stock for the 5 days prior to the end of the quarter and are distributable as stock upon cessation of director service, death, retirement or a change of control.

F2 · derivative.exercise_date: Represents stock units credited to the Reporting Person's account as of December 31, 2003, at a price of $25.17 per unit pursuant to the Issuer's exempt Deferred Compensation Plan for Directors (the 'Plan'). Director's fees and retainers are deferred quarterly under the Plan as Common Stock based on the average closing price of the stock for the 5 days prior to the end of the quarter and are distributable as stock upon cessation of director service, death, retirement or a change of control.

F2 · derivative.expiration_date: Represents stock units credited to the Reporting Person's account as of December 31, 2003, at a price of $25.17 per unit pursuant to the Issuer's exempt Deferred Compensation Plan for Directors (the 'Plan'). Director's fees and retainers are deferred quarterly under the Plan as Common Stock based on the average closing price of the stock for the 5 days prior to the end of the quarter and are distributable as stock upon cessation of director service, death, retirement or a change of control.

Read SEC document
September 27, 2003 Filed Sep 30, 2003 18:37 UTC THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 GrantPhantom Stock Units · Derivative 821.86 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0000097745-03-000151 · ull158.xml · derivative · entry 1

ULLIAN ELAINE · CIK 0001190290 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,507.97

Underlying: Common Stock · 821.86 shares

Expires not disclosed

F1 · derivative.exercise_price: Convertible into Common Stock on a 1-for-1 basis.

F2 · price: Represents stock units credited to the Reporting Person's account as of September 27, 2003, at a price of $22.51 per unit pursuant to the Issuer's exempt Deferred Compensation Plan for Directors (the 'Plan'). Director's fees and retainers are deferred quarterly under the Plan as Common Stock based on the average closing price of the stock for the 5 days prior to the end of the quarter and are distributable as stock upon cessation of director service, death, retirement or a change of control.

F2 · derivative.exercise_date: Represents stock units credited to the Reporting Person's account as of September 27, 2003, at a price of $22.51 per unit pursuant to the Issuer's exempt Deferred Compensation Plan for Directors (the 'Plan'). Director's fees and retainers are deferred quarterly under the Plan as Common Stock based on the average closing price of the stock for the 5 days prior to the end of the quarter and are distributable as stock upon cessation of director service, death, retirement or a change of control.

F2 · derivative.expiration_date: Represents stock units credited to the Reporting Person's account as of September 27, 2003, at a price of $22.51 per unit pursuant to the Issuer's exempt Deferred Compensation Plan for Directors (the 'Plan'). Director's fees and retainers are deferred quarterly under the Plan as Common Stock based on the average closing price of the stock for the 5 days prior to the end of the quarter and are distributable as stock upon cessation of director service, death, retirement or a change of control.

Read SEC document
June 28, 2003 Filed Jun 30, 2003 21:12 UTC THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 GrantPhantom Stock Units · Derivative 646.45 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0000097745-03-000109 · ull116.xml · derivative · entry 1

ULLIAN ELAINE · CIK 0001190290 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,686.11

Underlying: Common Stock · 646.45 shares

Expires 1988-08-08

F1 · derivative.exercise_price: Convertible into Common Stock on a 1-for-1 basis.

F2 · price: Represents stock units credited to the Reporting Person's account as of June 28, 2003, at a price of $21.27 per unit pursuant to the Issuer's exempt Deferred Compensation Plan for Directors (the 'Plan'). Director's fees and retainers are deferred quarterly under the Plan as Common Stock based on the average closing price of the stock for the 5 days prior to the end of the quarter and are distributable as stock upon cessation of director service, death, retirement or a change of control.

F2 · derivative.exercise_date: Represents stock units credited to the Reporting Person's account as of June 28, 2003, at a price of $21.27 per unit pursuant to the Issuer's exempt Deferred Compensation Plan for Directors (the 'Plan'). Director's fees and retainers are deferred quarterly under the Plan as Common Stock based on the average closing price of the stock for the 5 days prior to the end of the quarter and are distributable as stock upon cessation of director service, death, retirement or a change of control.

F2 · derivative.expiration_date: Represents stock units credited to the Reporting Person's account as of June 28, 2003, at a price of $21.27 per unit pursuant to the Issuer's exempt Deferred Compensation Plan for Directors (the 'Plan'). Director's fees and retainers are deferred quarterly under the Plan as Common Stock based on the average closing price of the stock for the 5 days prior to the end of the quarter and are distributable as stock upon cessation of director service, death, retirement or a change of control.

Read SEC document
June 01, 2003 Filed Jun 3, 2003 18:38 UTC VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 GrantStock Option · Derivative 7,500 $0.00 Strike: $14.46 $0.00
Disclosure

SEC source: 0000875320-03-000013 · edgar.xml · derivative · entry 1

ULLIAN ELAINE · CIK 0001190290 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 92,500

Underlying: Common Stock · 7,500 shares

Expires 2013-05-31

F1 · derivative.exercise_date: Right to buy under the 1996 Stock and Option Plan. Fully vested.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.